UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Immune Exclusion in Cancer Immunotherapy
Immune Exclusion in Cancer Immunotherapy is a funding opportunity from UNIVERSITY OF PITTSBURGH AT PITTSBURGH, up to 604941, closing July 31, 2027.
Jul 31, 2027
(365d left)Overview
ABSTRACT Most patients with solid tumors do not benefit from immune-checkpoint inhibition, emphasizing the need to improve immunotherapy. We have demonstrated that the T cell-inflamed tumor microenvironment (TME), characterized by CD8+ T cells and type I/II interferon (IFN) gene expression, is an important cancer…